[
    "{\"step_by_step_thinking\": \"Based on the provided documents, there is evidence to suggest that the use of bDMARDs during pregnancy does not have a negative impact on neonatal development. Document [0] states that exposure to bDMARDs during pregnancy does not seem to interfere with post-natal development up to infancy. Document [1] also supports this, stating that there were no major concerns or increased risk of adverse pregnancy outcomes for maternal or paternal exposures to non-TNFi bDMARDs. Additionally, Document [9] mentions that there were no major malformations reported in children whose mothers received bDMARDs. Therefore, the answer is B. no.\", \"answer_choice\": \"B\"}"
]